This topic contains a solution. Click here to go to the answer

Author Question: The Steady learner: a.Does well in school as many teachers have this learning/teaching ... (Read 21 times)

lunatika

  • Hero Member
  • *****
  • Posts: 548
The Steady learner:
 
  a.Does well in school as many teachers have this learning/teaching styleb.Likes to study in groupsc.Is a risk taker

Question 2

The Interactive Social learner:
 
  a.Has to have a lecture in order to be able to learnb.Likes to talk while learningc.Seldom enjoys solitude



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kiamars2010

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

ANSWER:
A

Answer to Question 2

ANSWER:
B



lunatika

  • Hero Member
  • *****
  • Posts: 548
Both answers were spot on, thank you once again



kiamars2010

  • Sr. Member
  • ****
  • Posts: 341

 

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library